
BLS Pharmaceuticals has rapidly transformed into a profitable regulated-medicines manufacturer, supported by strong revenue growth, controlled-substance licences and international expansion. While FY26 guidance remains ambitious, bearish RSI divergence suggests traders should monitor key support levels closely.
.webp&w=828&q=75)
Sinclair Gold is advancing its Mt Henry gold project in Western Australia through drilling, funding, and resource growth plans. The company aims to expand its 915,000-ounce resource while testing deeper mineralisation and preparing for a late-2026 resource update.
.webp&w=828&q=75)
Karoon Energy (ASX: KAR) delivers resilient production, strong cash margins and a two‑hub growth pipeline across Brazil and the US Gulf, positioning for higher free cash flow in 2H26 and multi‑year expansion.
.webp&w=828&q=75)
Liontown is transitioning from development to production as Kathleen Valley ramps up. While operational progress continues, weakness in the lithium market and technical selling have weighed sentiment, making execution, costs, and expansion progress key factors for investors.
.webp&w=828&q=75)
Aeris Resources (ASX: AIS) delivers solid FY26 production, strong cash generation, and transformational growth via South Cobar acquisition, positioning for sustained copper‑gold expansion into FY27.
.webp&w=828&q=75)
Vulcan Energy Resources (ASX: VUL) advances its Zero Carbon Lithium project with progressing development, strategic partnerships, and strengthened funding pathways, positioning the company as a unique European lithium supplier amid rising demand for decarbonised battery materials.